REFERENCES
- Perez de los Cobos J, Trujols J, Valderrama JC, Valero S, Puig T. Patient perspectives on methadone maintenance treatment in the Valencia Region: Dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend 2005; 79:405–412.
- World Health Organization (WHO). Client Satisfaction Evaluations. Workbook 6. Geneva: World Health Organization, 2000.
- Bryant J, Saxton M, Madden A, Bath N, Robinson S. Consumers’ and providers’ perspectives about consumer participation in drug treatment services: Is there support to do more? What are the obstacles? Drug Alcohol Rev 2008; 27:138–144.
- Madden A, Lea T, Bath N, Winstock AR. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug Alcohol Rev 2008; 27:671–678.
- Simpson DD, Joe GW, Rowan-Szal GA, Greener J. Drug abuse treatment process components that improve retention. J Subst Abuse Treat 1997; 14:565–572.
- Zhang Z, Gerstein DR, Friedmann PD. Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol 2008; 13:388–400.
- McLellan AT, Woody GE, Metzger D, McKay J, Durrell J, Alterman AI, O’Brien CP. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. Milbank Q 1996; 74:51–85.
- Hogan B, Hershey L, Ritchey S. A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: Marketing implications and organizational impact. Health Mark Q 2007; 24:93–106.
- Simpson DD, Joe GW, Rowan-Szal G, Greener J. Client engagement and change during drug abuse treatment. J Subst Abuse 1995; 7:117–134.
- Joe GW, Friend HJ. Treating process factors and satisfaction with drug abuse treatment. Psychology of Addictive Behaviors 1989; 3:53–64.
- Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS. In-treatment vs. out-of-treatment opioid dependent adults: Drug use and criminal history. Am J Drug Alcohol Abuse 2008; 34:17–28.
- Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse 2009; 35:38–42.
- McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199–213.
- Simpson DD. A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat 2004; 27:99–121.
- Joe GW, Broome KM, Rowan-Szal GA, Simpson DD. Measuring patient attributes and engagement in treatment. J Subst Abuse Treat 2002; 22:183– 96.
- Simpson DD, Dansereau DF, Joe GW. The DATAR project: Cognitive and behavioral enhancements to community-based treatments. In Tim FM, Inciardi JA, Fletcher BW, Horton AM, Jr., (eds., translator and editor). The Effectiveness of Innovative Strategies in the Treatment of Drug Abuse. Westport, CT: Greenwood Press, 1997; 182–203.
- Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill: University of North Carolina Press, 1989.
- Woody GE, McLellan AT, Luborsky L, O’Brien CP. Psychotherapy in community methadone programs: A validation study. Am J Psychiatry 1995; 152:1302–1308.
- Asche SE, Harrison PA. The relationship between problem severity and ancillary treatment services: Is substance abuse treatment responsive to client need? J Behav Health Serv Res 2002; 29:345–356.
- Del Boca FK, Noll JA. Truth or consequences: The validity of self-report data in health services research on addictions. Addiction 2000; 95 Suppl 3:S347–360.